ID   UT56
AC   CVCL_VK01
DR   Cosmic; 2653724
DR   GEO; GSM2375334
DR   GEO; GSM2386071
DR   Wikidata; Q98134389
RX   PubMed=28256713;
CC   Population: Chinese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=28256713
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 19,22
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 15,16
ST   D19S433: 14,14.2
ST   D21S11: 29,30
ST   D2S1338: 24,26
ST   D3S1358: 18
ST   D5S818: 13
ST   D6S1043: 14
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   Penta E: 15,18
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
RX   PubMed=28256713; DOI=10.1002/ijc.30674;
RA   Feng H.-L., Zhang Y., Liu K., Zhu Y., Yang Z.-L., Zhang X., Liu Y.-Q.;
RT   "Intrinsic gene changes determine the successful establishment of
RT   stable renal cancer cell lines from tumor tissue.";
RL   Int. J. Cancer 140:2526-2534(2017).
//